2014China Modern MedicineRequires access

Effect observation of edaravone combined with low molecular heparin calcium treating progressive cerebral infarction

Song Zh

Open publisher page 0 citations

Abstract

Objective To discuss the clinical effect of edaravone combined with low molecular heparin calcium treating progressive cerebral infarction. Methods 142 patients with progressive cerebral infarction were equally divided into the observation and the control groups.Both groups received conventional symptomatic treatment,and the control group was additionally provided with edaravone,while the observation group was offered edaravone combined with low molecular heparin calcium.The treatment effect of patients in the two groups was observed. Results NIHSS score in the observation group was visibly lower than that in the control group after treatment(P0.05),the basic cure rate and the total effective rate in the observation group(36.62%,90.14% respectively) was obviously higher than that in the control group(11.27%,69.01% respectively)(P0.05). Conclusion Edaravone combined with low molecular heparin calcium treating progressive cerebral has advantages of good effect,obvious improvement of neurological etc with good safely.

About this research paper

What this paper is about

Objective To discuss the clinical effect of edaravone combined with low molecular heparin calcium treating progressive cerebral infarction. Methods 142 patients with progressive cerebral infarction were equally divided into the observation and the control groups.Both groups received conventional symptomatic treatment,and the control group was additionally provided with edaravone,while the observation group was offered edaravone combined with low molecular heparin calcium.The treatment effect of patients in the two groups was observed. Results NIHSS score in the observation group was visibly lower than that in the control group after treatment(P0.05),the basic cure rate and the total effective rate in the observation group(36.62%,90.14% respectively) was obviously higher than that in the control group(11.27%,69.01% respectively)(P0.05). Conclusion Edaravone combined with low molecular heparin calcium treating progressive cerebral has advantages of good effect,obvious improvement of neurological etc with good safely.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To discuss the clinical effect of edaravone combined with low molecular heparin calcium treating progressive cerebral infarction. Methods 142 patients with progressive cerebral infarction were equally divided into the observation and the control groups.Both groups received conventional symptomatic treatment,and the control group was additionally provided with edaravone,while the observation group was offered edaravone combined with low molecular heparin calcium.The treatment effect of patients in the two groups was observed. Results NIHSS score in the observation group was visibly lower than that in the control group after treatment(P0.05),the basic cure rate and the total effective rate in the observation group(36.62%,90.14% respectively) was obviously higher than that in the control group(11.27%,69.01% respectively)(P0.05). Conclusion Edaravone combined with low molecular heparin calcium treating progressive cerebral has advantages of good effect,obvious improvement of neurological etc with good safely.

Key concepts: Edaravone, Medicine, Cerebral infarction, Heparin, Anesthesia, Calcium, Clinical efficacy, Cure rate

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect observation of edaravone combined with low molecular heparin calcium treating progressive cerebral infarction — Research Paper | ScholarLens